Concepedia
Statistics
Publications
14
Citations
1.3K
H-Index
13
Active since
1992
Affiliations
Eli Lilly (United States)(Current)
Indiana University – Purdue University Indianapolis
Indiana University School of Medicine
Eli Lilly (United Kingdom)
University of Wisconsin–Madison
Karla Alaka is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and chronic kidney disease.
Top concepts
MedicinePharmacotherapyHealthUrologyNephrologyHemodialysisPain MedicinePain ResearchAnesthesiologyPain Treatment
Publications per year
1992–2019
Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia
Pádraig Wright, Martin Birkett, S.R. David et al. · American Journal of Psychiatry · 2001 · 301 citations
Duloxetine Versus Placebo in Patients With Chronic Low Back Pain: A 12-Week, Fixed-Dose, Randomized, Double-Blind Trial
Vladimir Skljarevski, Shuyu Zhang, D. Desaiah et al. · Journal of Pain · 2010 · 188 citations
Pain Therapy, Duloxetine Versus Placebo, Health Sciences +12
A comparison of metabolic control by continuous and intermittent therapies in acute renal failure.
William R. Clark, Bruce A. Mueller, Karla Alaka et al. · Journal of the American Society of Nephrology · 1994 · 164 citations
Hypertension, Heart Failure, Peak Ihd Sun +21
Impact of the Nutritional Regimen on Protein Catabolism and Nitrogen Balance in Patients With Acute Renal Failure
William L. Macias, Karla Alaka, Mary H. Murphy et al. · Journal of Parenteral and Enteral Nutrition · 1996 · 118 citations
Calming versus sedative effects of intramuscular olanzapine in agitated patients
John Battaglia, Stacy Lindborg, Karla Alaka et al. · The American Journal of Emergency Medicine · 2003 · 105 citations
Psychoactive Drug, Psychiatry, Psychotropic Medication +10
1–5 of 14